Literature DB >> 12756794

F1-negative natural Y. pestis strains.

Tatyana V Meka-Mechenko1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756794     DOI: 10.1007/0-306-48416-1_76

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  11 in total

1.  The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background.

Authors:  Eric H Weening; Jason S Cathelyn; Greer Kaufman; Matthew B Lawrenz; Paul Price; William E Goldman; Virginia L Miller
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

Review 2.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.

Authors:  Shilpa Sanapala; Hannah Rahav; Hetal Patel; Wei Sun; Roy Curtiss
Journal:  Vaccine       Date:  2016-04-06       Impact factor: 3.641

4.  The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague.

Authors:  Florent Sebbane; Clayton Jarrett; Donald Gardner; Daniel Long; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

5.  Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector.

Authors:  Ling Cao; Timothy Lim; SangMu Jun; Theresa Thornburg; Recep Avci; Xinghong Yang
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 6.  Functional and structural characteristics of bacterial proteins that bind host cytokines.

Authors:  Martin Högbom; Riikka Ihalin
Journal:  Virulence       Date:  2017-08-25       Impact factor: 5.882

Review 7.  Plague vaccine: recent progress and prospects.

Authors:  Wei Sun; Amit K Singh
Journal:  NPJ Vaccines       Date:  2019-02-18       Impact factor: 9.399

8.  A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform.

Authors:  Paul B Kilgore; Jian Sha; Jourdan A Andersson; Vladimir L Motin; Ashok K Chopra
Journal:  NPJ Vaccines       Date:  2021-01-29       Impact factor: 7.344

Review 9.  Antibiotic Therapy of Plague: A Review.

Authors:  Florent Sebbane; Nadine Lemaître
Journal:  Biomolecules       Date:  2021-05-12

10.  Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.

Authors:  Paul B Kilgore; Jian Sha; Emily K Hendrix; Vladimir L Motin; Ashok K Chopra
Journal:  mBio       Date:  2021-12-07       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.